Skip to main content

Table 2 Baseline descriptive characteristics of enrolled participants (N = 454)

From: Development and validation of a novel scale for antiretroviral therapy readiness among pregnant women in urban Zambia with newly diagnosed HIV infection

Characteristics at baseline

Study arm

p-value

BEAP (n = 229)

Standard-of-care (n = 225)

Age, years

26.3 (23.3–31.7)

27.5 (24.0–32.0)

0.16

Gestational age, weeks

22 (18–25)

23 (19–26)

0.09

Number of Pregnancies

3 (2–4)

3 (2–4)

0.23

Number of live births

2 (1–3)

2 (1–3)

0.37

Marital status

  

0.48

Cohabitating/Married

200 (87.3)

199 (88.4)

 

Single/Widowed/Divorced

29 (12.7)

26 (11.6)

 

Educational level

  

0.28

None

15 (6.6)

11 (4.9)

 

Nursery/Primary

69 (30.1)

87 (38.7)

 

 >  = Secondary

145 (63.3)

127 (56.4)

 

Initiated ART on same day as diagnosisa

167 (72.9)

172 (76.8)

0.30

Initiated ART at/before enrollment

204 (89.1)

208 (92.4)

0.32

CD4 Countb

287 (195.5–392.5)

317 (201–426)

0.20

CD4 Countb

  

0.14

 < 350 cells/mm3

113 (64.2)

99 (56.6)

 

 ≥ 350 cells/mm3

63 (35.8)

76 (43.4)

 

Clinic

  

1.00

Kanyama

76 (33.2)

75 (33.3)

 

Chawama

77 (33.6)

75 (33.3)

 

Matero

76 (33.2)

75 (33.3)

 

Disclosure of HIV status to male partner at/before enrollment

84 (36.7)

73 (32.4)

0.22

Participant aware of male partner’s HIV status

77 (33.6)

64 (28.4)

0.28

Of those aware, whose partner is positive

39 (50.6)

40 (62.5)

0.25

  1. Reprinted from “Effect of enhanced adherence package on early ART uptake among HIV-positive pregnant women in Zambia: an individual randomized controlled trial”, by Mubiana-Mbewe, M. AIDS and Behaviour 2021 Mar; 25(3):992–1000 [11]
  2. *Data are in n (%) or Median (IQR) with Chi-Squared and Wilcoxon Rank-Sum p-values, respectively
  3. a1 missing value (0.22%)
  4. b103 missing values (23%)